Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  p38 MAPK inhibitor LY2228820 dimesylate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of LY2228820 for Recurrent Ovarian Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12517, NCI-2012-01426, I1D-MC-JIAE, NCT01663857
Start Over